517 related articles for article (PubMed ID: 24840266)
1. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.
Page MM; Bell DA; Hooper AJ; Watts GF; Burnett JR
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):387-403. PubMed ID: 24840266
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Ten years of lipoprotein apheresis for familial hypercholesterolemia in Malaysia: A creative approach by a cardiologist in a developing country.
Khoo KL; Page MM; Liew YM; Defesche JC; Watts GF
J Clin Lipidol; 2016; 10(5):1188-94. PubMed ID: 27678436
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia.
Vella A; Pineda AA; O'Brien T
Mayo Clin Proc; 2001 Oct; 76(10):1039-46. PubMed ID: 11605688
[TBL] [Abstract][Full Text] [Related]
5. [Position of lipoprotein apheresis in present].
Bláha V; Bláha M; Lánská M; Havel E; Vyroubal P; Zadák Z; Vrablík M; Piťha J; Žák P; Sobotka L
Vnitr Lek; 2015 Nov; 61(11):958-64. PubMed ID: 26652784
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
[TBL] [Abstract][Full Text] [Related]
7. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.
Raal FJ; Santos RD
Atherosclerosis; 2012 Aug; 223(2):262-8. PubMed ID: 22398274
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.
Stefanutti C; Thompson GR
Curr Atheroscler Rep; 2015 Jan; 17(1):465. PubMed ID: 25410046
[TBL] [Abstract][Full Text] [Related]
9. The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies.
Ooi EM; Barrett PH; Watts GF
Int J Cardiol; 2013 Oct; 168(3):1811-8. PubMed ID: 23907036
[TBL] [Abstract][Full Text] [Related]
10. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
Thiery J; Seidel D
Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
[TBL] [Abstract][Full Text] [Related]
11. Removal of plasma mature and furin-cleaved proprotein convertase subtilisin/kexin 9 by low-density lipoprotein-apheresis in familial hypercholesterolemia: development and application of a new assay for PCSK9.
Hori M; Ishihara M; Yuasa Y; Makino H; Yanagi K; Tamanaha T; Kishimoto I; Kujiraoka T; Hattori H; Harada-Shiba M
J Clin Endocrinol Metab; 2015 Jan; 100(1):E41-9. PubMed ID: 25313916
[TBL] [Abstract][Full Text] [Related]
12. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
Vishwanath R; Hemphill LC
J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
[TBL] [Abstract][Full Text] [Related]
13. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Robinson JG
J Manag Care Pharm; 2013 Mar; 19(2):139-49. PubMed ID: 23461430
[TBL] [Abstract][Full Text] [Related]
14. Homozygous familial hypercholesterolaemia: update on management.
France M
Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
[TBL] [Abstract][Full Text] [Related]
15. Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia.
Bell DA; Hooper AJ; Watts GF; Burnett JR
Vasc Health Risk Manag; 2012; 8():651-9. PubMed ID: 23226021
[TBL] [Abstract][Full Text] [Related]
16. Familial Hypercholesterolemia and Lipoprotein Apheresis.
Makino H; Koezuka R; Tamanaha T; Ogura M; Matsuki K; Hosoda K; Harada-Shiba M
J Atheroscler Thromb; 2019 Aug; 26(8):679-687. PubMed ID: 31231083
[TBL] [Abstract][Full Text] [Related]
17. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
McGowan MP
J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
[TBL] [Abstract][Full Text] [Related]
18. My Approach to the Patient With Familial Hypercholesterolemia.
Safarova MS; Kullo IJ
Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
[TBL] [Abstract][Full Text] [Related]
19. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
Bourbon M; Rato Q;
Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
[TBL] [Abstract][Full Text] [Related]
20. Lipid apheresis, indications, and principles.
Winters JL
J Clin Apher; 2011; 26(5):269-75. PubMed ID: 21834078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
